Phase 3 Embolism Clinical Trials

24 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 120 of 24 trials

Recruiting
Phase 3

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

Pulmonary Embolism
NYU Langone Health500 enrolled40 locationsNCT05591118
Recruiting
Phase 3

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Symptomatic Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled14 locationsNCT07213778
Recruiting
Phase 3

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled41 locationsNCT07015905
Recruiting
Phase 3

Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis

Venous Thromboembolism (VTE)Postpartum
Marc Blondon9,200 enrolled1 locationNCT07140211
Recruiting
Phase 3

DOAC - Dosing Options in AntiCoagulation Prophylaxis

CancerVTE (Venous Thromboembolism)
University of Vermont996 enrolled1 locationNCT07005024
Recruiting
Phase 3

The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

Metastatic Pancreatic CancerVenous ThromboembolismLocally Advanced Pancreatic Adenocarcinoma
Quercis Pharma AG480 enrolled3 locationsNCT06861088
Recruiting
Phase 3

Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism

Venous ThromboembolismGastro Intestinal BleedingBlood Clot
Ottawa Hospital Research Institute360 enrolled7 locationsNCT06393868
Recruiting
Phase 3

Statins for Venous Event Reduction in Patients With Venous Thromboembolism

Venous ThromboembolismBlood ClotPost Thrombotic Syndrome
Ottawa Hospital Research Institute2,700 enrolled31 locationsNCT04319627
Recruiting
Phase 3

Low INR to Minimize Bleeding With Mechanical Valves Trial

Bleeding Post-mechanical Valve ReplacementThromboembolism Post-mechanical Valve Replacement
Population Health Research Institute2,625 enrolled35 locationsNCT03636295
Recruiting
Phase 3

Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)

Venous Thromboembolism
Ottawa Hospital Research Institute150 enrolled3 locationsNCT06440694
Recruiting
Phase 3

RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing

Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis+3 more
University Hospital, Angers1,424 enrolled35 locationsNCT06195540
Recruiting
Phase 3

Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism

Pulmonary Embolism
Supergene, LLC486 enrolled24 locationsNCT06362746
Recruiting
Phase 2Phase 3

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

Urologic CancerVenous Thromboembolism
Ottawa Hospital Research Institute120 enrolled1 locationNCT05920343
Recruiting
Phase 3

Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters

CancerVenous Thromboembolism
Ottawa Hospital Research Institute1,828 enrolled11 locationsNCT05029063
Recruiting
Phase 3

Pulmonary Embolism International THrOmbolysis Study-3

Pulmonary Embolism
Assistance Publique - Hôpitaux de Paris800 enrolled98 locationsNCT04430569
Recruiting
Phase 3

ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty

Hip Arthroplasty, TotalPrevention of Venous Thromboembolism
Prof. Stavros Konstantinides, MD2,932 enrolled6 locationsNCT06611319
Recruiting
Phase 3

Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)

ElderlyVenous ThromboembolismAnticoagulant
Arianna Anticoagulazione Foundation1,455 enrolled1 locationNCT04257487
Recruiting
Phase 3

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

Venous Thromboembolism
Second Affiliated Hospital, School of Medicine, Zhejiang University200 enrolled7 locationsNCT04066764
Recruiting
Phase 3

VTE Prevention Following Total Hip and Knee Arthroplasty

Venous Thromboembolism
Sudeep Shivakumar5,400 enrolled1 locationNCT04075240
Completed
Phase 3

Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies (TARGET-TP)

Liver CancerPancreatic CancerLung Cancer+4 more
Peter MacCallum Cancer Centre300 enrolled5 locationsACTRN12618000811202